Rezolute (RZLT) Shares Issued (2017 - 2026)
Rezolute (RZLT) posted Shares Issued of $12.4 million for Q1 2026, down 5.63% sequentially from $13.2 million in Q4 2025, and up 393.42% YoY from $2.5 million in Q1 2025.
Rezolute (RZLT) Shares Issued (2017 - 2026) Analysis & Trends
Rezolute has reported Shares Issued for 10 years, with the latest figure at $12.4 million in Q1 2026.
- Quarterly Shares Issued rose 393.42% year-over-year to $12.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (up 393.42% YoY) and the FY2025 annual result came in at $13.0 million, up 19.63% from the prior year.
- Shares Issued eased to $12.4 million in Q1 2026 per RZLT's latest filing, from $13.2 million in the prior quarter.
- Over five years, Shares Issued peaked at $13.2 million in Q4 2025 and troughed at $118000.0 in Q1 2022.
- A 5-year average of $6.5 million and a median of $8.5 million in 2022 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2025: Shares Issued surged 1830.51% in 2023, then plunged 90.86% in 2025.
- Over 5 years, Shares Issued stood at $2.7 million in 2022, then declined by 23.71% to $2.0 million in 2023, then soared by 441.05% to $11.0 million in 2024, then grew by 20.02% to $13.2 million in 2025, then declined by 5.63% to $12.4 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $12.4 million, $13.2 million, and $985076.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 12.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.42 Mn |
| Mar 31, 2026 | 12.42 Mn |
| Dec 31, 2025 | 13.16 Mn |
| Dec 31, 2025 | 13.16 Mn |
| Sep 30, 2025 | 985,076.00 |
| Sep 30, 2025 | 985,076.00 |
| Jun 30, 2025 | 13.03 Mn |
| Jun 30, 2025 | 13.03 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 10.97 Mn |
| Dec 31, 2024 | 10.97 Mn |
| Sep 30, 2024 | 10.78 Mn |
| Sep 30, 2024 | 10.78 Mn |
| Jun 30, 2024 | 10.89 Mn |
| Jun 30, 2024 | 10.89 Mn |
| Mar 31, 2024 | 402,000.00 |
| Mar 31, 2024 | 402,000.00 |
| Dec 31, 2023 | 2.03 Mn |
| Dec 31, 2023 | 2.03 Mn |